Stonehearth Capital Management LLC Buys 1,010 Shares of Johnson & Johnson (NYSE:JNJ)

Share on StockTwits

Stonehearth Capital Management LLC boosted its stake in shares of Johnson & Johnson (NYSE:JNJ) by 35.9% during the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 3,825 shares of the company’s stock after acquiring an additional 1,010 shares during the quarter. Stonehearth Capital Management LLC’s holdings in Johnson & Johnson were worth $533,000 as of its most recent SEC filing.

Other large investors also recently modified their holdings of the company. Highwater Wealth Management LLC purchased a new stake in Johnson & Johnson in the 4th quarter valued at $215,000. Alta Capital Management LLC grew its holdings in Johnson & Johnson by 12.5% in the 4th quarter. Alta Capital Management LLC now owns 1,800 shares of the company’s stock valued at $232,000 after buying an additional 200 shares in the last quarter. Grassi Investment Management grew its holdings in Johnson & Johnson by 10.5% in the 4th quarter. Grassi Investment Management now owns 67,530 shares of the company’s stock valued at $8,715,000 after buying an additional 6,405 shares in the last quarter. Arlington Partners LLC grew its holdings in Johnson & Johnson by 3.0% in the 4th quarter. Arlington Partners LLC now owns 8,400 shares of the company’s stock valued at $1,084,000 after buying an additional 245 shares in the last quarter. Finally, Lynch & Associates IN grew its holdings in Johnson & Johnson by 1.7% in the 4th quarter. Lynch & Associates IN now owns 97,145 shares of the company’s stock valued at $12,537,000 after buying an additional 1,648 shares in the last quarter. 66.83% of the stock is currently owned by hedge funds and other institutional investors.

In other Johnson & Johnson news, Director Marillyn A. Hewson purchased 3,000 shares of the firm’s stock in a transaction dated Tuesday, June 11th. The shares were acquired at an average price of $139.68 per share, with a total value of $419,040.00. Following the purchase, the director now directly owns 3,000 shares in the company, valued at approximately $419,040. The purchase was disclosed in a filing with the SEC, which is accessible through the SEC website. Corporate insiders own 0.23% of the company’s stock.

JNJ has been the subject of several analyst reports. Royal Bank of Canada upped their target price on Johnson Service Group from GBX 180 ($2.35) to GBX 190 ($2.48) and gave the company an “outperform” rating in a report on Tuesday, July 16th. Credit Suisse Group restated a “buy” rating and issued a $90.00 target price on shares of Bayerische Motoren Werke in a report on Thursday, July 18th. Raymond James restated a “reduce” rating and issued a $48.00 target price (up from $45.00) on shares of Hancock Whitney in a report on Wednesday, July 17th. Morgan Stanley set a $60.00 target price on Berry Global Group and gave the company a “hold” rating in a report on Wednesday, April 17th. Finally, Goldman Sachs Group set a $27.00 target price on Melco Resorts & Entertainment and gave the company a “buy” rating in a report on Tuesday, May 28th. Five investment analysts have rated the stock with a hold rating and eight have given a buy rating to the company. Johnson & Johnson presently has a consensus rating of “Buy” and an average target price of $148.56.

Shares of Johnson & Johnson stock opened at $129.78 on Thursday. Johnson & Johnson has a 52 week low of $121.00 and a 52 week high of $148.99. The company has a fifty day simple moving average of $138.09. The firm has a market cap of $342.08 billion, a price-to-earnings ratio of 15.87, a PEG ratio of 2.18 and a beta of 0.70. The company has a current ratio of 1.44, a quick ratio of 1.13 and a debt-to-equity ratio of 0.47.

Johnson & Johnson (NYSE:JNJ) last announced its quarterly earnings results on Tuesday, July 16th. The company reported $2.58 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $2.42 by $0.16. Johnson & Johnson had a return on equity of 38.57% and a net margin of 20.08%. The business had revenue of $20.56 billion for the quarter, compared to analyst estimates of $20.39 billion. During the same quarter in the prior year, the company posted $2.10 EPS. The company’s quarterly revenue was down 1.3% on a year-over-year basis. On average, research analysts expect that Johnson & Johnson will post 8.6 earnings per share for the current year.

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, September 10th. Stockholders of record on Tuesday, August 27th will be paid a $0.95 dividend. This represents a $3.80 annualized dividend and a dividend yield of 2.93%. The ex-dividend date of this dividend is Monday, August 26th. Johnson & Johnson’s dividend payout ratio (DPR) is presently 46.45%.

Johnson & Johnson Profile

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the health care field worldwide. It operates in three segments: Consumer, Pharmaceutical, and Medical Devices. The Consumer segment offers baby care products under the JOHNSON'S brand; oral care products under the LISTERINE brand; beauty products under the AVEENO, CLEAN & CLEAR, DABAO, JOHNSON'S Adult, LE PETITE MARSEILLAIS, NEUTROGENA, and OGX brands; over-the-counter medicines, including acetaminophen products under the TYLENOL brand; cold, flu, and allergy products under the SUDAFED brand; allergy products under the BENADRYL and ZYRTEC brands; ibuprofen products under the MOTRIN IB brand; and acid reflux products under the PEPCID brand.

Featured Article: Net Margin – Understanding the Different Kinds of Profit

Institutional Ownership by Quarter for Johnson & Johnson (NYSE:JNJ)

Receive News & Ratings for Johnson & Johnson Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Johnson & Johnson and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Markel Corp Acquires 2,400 Shares of JPMorgan Chase & Co.
Markel Corp Acquires 2,400 Shares of JPMorgan Chase & Co.
Walt Disney Co  is K.J. Harrison & Partners Inc’s 10th Largest Position
Walt Disney Co is K.J. Harrison & Partners Inc’s 10th Largest Position
Walt Disney Co  Holdings Boosted by Matthew Goff Investment Advisor LLC
Walt Disney Co Holdings Boosted by Matthew Goff Investment Advisor LLC
McKinley Carter Wealth Services Inc. Has $1.34 Million Position in Cisco Systems, Inc.
McKinley Carter Wealth Services Inc. Has $1.34 Million Position in Cisco Systems, Inc.
Qube Research & Technologies Ltd Lowers Stock Holdings in Cisco Systems, Inc.
Qube Research & Technologies Ltd Lowers Stock Holdings in Cisco Systems, Inc.
Cisco Systems, Inc.  Shares Sold by Quest Capital Management Inc. ADV
Cisco Systems, Inc. Shares Sold by Quest Capital Management Inc. ADV


© 2006-2019 Ticker Report